EXELON 2 mg/ml, oral solution bottle, 50 ml
Active ingredients: Rivastigmine tartrate, Rivastigmine
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 50 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EXELON 2 mg/ml, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun avec fermeture de sécurité enfant de 50 ml avec seringue(s) doseuse(s)
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 23 Jan 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67070657CIP73634892CIP133400936348929Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RIVASTIGMINE BASEsolution | 2 mg · 1 ml | FT |
| HYDROGÉNOTARTRATE DE RIVASTIGMINEsolution | 3,2 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.